Point72 Asia Singapore Pte. Ltd. Reduces Stake in Phibro Animal Health Co. (NASDAQ:PAHC)

Point72 Asia Singapore Pte. Ltd. decreased its stake in shares of Phibro Animal Health Co. (NASDAQ:PAHC) by 55.3% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 3,031 shares of the company’s stock after selling 3,745 shares during the period. Point72 Asia Singapore Pte. Ltd.’s holdings in Phibro Animal Health were worth $51,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of PAHC. Wellington Management Group LLP raised its holdings in shares of Phibro Animal Health by 165.9% in the 4th quarter. Wellington Management Group LLP now owns 164,764 shares of the company’s stock valued at $1,908,000 after acquiring an additional 102,793 shares in the last quarter. Los Angeles Capital Management LLC bought a new position in Phibro Animal Health during the 1st quarter worth approximately $377,000. Bridge City Capital LLC grew its position in Phibro Animal Health by 3.3% during the 1st quarter. Bridge City Capital LLC now owns 137,694 shares of the company’s stock worth $1,780,000 after acquiring an additional 4,433 shares during the last quarter. Cardinal Capital Management grew its position in Phibro Animal Health by 43.1% during the 1st quarter. Cardinal Capital Management now owns 53,507 shares of the company’s stock worth $692,000 after acquiring an additional 16,112 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC grew its position in Phibro Animal Health by 78.1% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 81,608 shares of the company’s stock worth $1,055,000 after acquiring an additional 35,788 shares during the last quarter. Hedge funds and other institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Stock Up 0.9 %

Phibro Animal Health stock opened at $21.31 on Friday. The firm has a market cap of $863.12 million, a price-to-earnings ratio of 66.59, a PEG ratio of 1.77 and a beta of 0.52. The stock has a fifty day simple moving average of $20.04 and a two-hundred day simple moving average of $17.55. Phibro Animal Health Co. has a 12 month low of $9.40 and a 12 month high of $22.84. The company has a current ratio of 2.94, a quick ratio of 1.64 and a debt-to-equity ratio of 1.79.

Phibro Animal Health (NASDAQ:PAHC) last posted its earnings results on Wednesday, August 28th. The company reported $0.41 EPS for the quarter, topping analysts’ consensus estimates of $0.34 by $0.07. The business had revenue of $273.16 million during the quarter, compared to analyst estimates of $262.44 million. Phibro Animal Health had a return on equity of 18.08% and a net margin of 0.24%. Equities analysts predict that Phibro Animal Health Co. will post 1.44 EPS for the current fiscal year.

Phibro Animal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Wednesday, September 4th were given a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 2.25%. The ex-dividend date was Wednesday, September 4th. Phibro Animal Health’s dividend payout ratio (DPR) is presently 150.00%.

Analyst Ratings Changes

Several equities analysts recently issued reports on PAHC shares. JPMorgan Chase & Co. initiated coverage on Phibro Animal Health in a research report on Tuesday, September 10th. They set a “neutral” rating and a $22.00 price target on the stock. Bank of America lifted their price objective on Phibro Animal Health from $13.00 to $15.00 and gave the stock an “underperform” rating in a research report on Friday, August 30th. Three equities research analysts have rated the stock with a sell rating, two have given a hold rating and one has issued a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $15.00.

Insider Activity at Phibro Animal Health

In other news, Director E Thomas Corcoran acquired 5,000 shares of Phibro Animal Health stock in a transaction that occurred on Wednesday, September 4th. The stock was bought at an average price of $20.02 per share, for a total transaction of $100,100.00. Following the completion of the transaction, the director now owns 25,000 shares in the company, valued at $500,500. The trade was a 0.00 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 50.06% of the stock is owned by company insiders.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.